Human chorionic gonadotropin (hCG) is a hormone for the maternal recognition of pregnancy produced by trophoblast cells that are surrounding a growing embryo (syncytiotrophoblast initially), which eventually forms the placenta after implantation. The presence of hCG is detected in some pregnancy tests (HCG pregnancy strip tests). Some cancerous tumors produce this hormone; therefore, elevated levels measured when the patient is not pregnant may lead to a diagnosis of cancer and, if high enough, of paraneoplastic syndromes. It is unknown however whether this production is a contributing cause or an effect of carcinogenesis. The pituitary analogue of hCG, luteinizing hormone (LH), is produced in the pituitary gland of males and females of all ages.
Read the full article on WikipediaInfertility indications other than that of Assisted Reproductive Technology Clinical criteria: Treatment criteria: Patient must not be undergoing treatment with medical services as described in items 13200, 13201, 13202 or 13203 of the Medicare Benefits Schedule, AND Patient must not be undergoing simultaneous treatment with this drug through another PBS program listing, AND Must be treated by an obstetrician/gynaecologist; OR Must be treated by a specialist in reproductive endocrinology/infertility; OR Must be treated by a urogynaecologist; OR Must be treated by an endocrinologist; OR Must be treated by a urologist. The PBS prescription, whether it is to initiate or continue treatment, must be made out under the specialist's prescriber number.
Assisted Reproductive Technology Clinical criteria: Patient must be receiving medical services as described in items 13200, 13201, 13202 or 13203 of the Medicare Benefits Schedule. Treatment criteria: Patient must not be undergoing simultaneous treatment with this drug through another PBS program listing.
Working under the parallel aged-care framework? Aged-care equivalent →